Patient Pathfinder: Clinical Trials
Clinical Trials for Esophageal Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 189 active Esophageal Cancer trials
Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
Study Type: Observational
A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer
Study Type: Interventional Phase 3
A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer
Study Type: Interventional Phase 2
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
Study Type: Observational
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
Study Type: Interventional Phase 1
EsophaCap for the Detection of Early Esophageal Carcinoma
Study Type: Observational
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
Study Type: Interventional Phase 2
There are 189 active Esophageal Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now